Taurine Dosage Guide: Protocols, Calculator & Safety
Everything you need to know about Taurine dosing — protocols, safety, and where to buy.
Dosage Calculator
Calculate exact dosing for Taurine.
Dosing Protocols
Beginner Protocol (foundational longevity and wellness support):
Week 1-2 (introduction):
- Choose a quality taurine product—pharmaceutical grade or USP-grade powder preferred for flexible dosing; capsules acceptable for convenience.
- Begin taurine 1 g (1,000 mg) daily with breakfast.
- Monitor for GI tolerance and any subjective changes.
- Note baseline: blood pressure, sleep quality, energy levels, exercise tolerance.
Week 3-8 (dose titration):
- Increase to 2 g (2,000 mg) daily if tolerating week 1-2 dose. Can be taken as single dose or split morning/evening.
- Continue monitoring subjective markers.
- Check blood pressure periodically, particularly if on antihypertensive medications (taurine may produce 4-5 mmHg reduction).
Month 3+ (maintenance):
- Most individuals can maintain on 2-3 g daily long-term.
- Periodically assess whether you're noticing subjective benefits (sleep, energy, cardiovascular measures).
- Reasonable to reassess need at 6 months; taurine tissue status builds over weeks and persists for weeks after discontinuation.
Specific situations:
For pre-workout use:
- Take 1-2 g taurine 30-60 minutes before exercise, often with caffeine (100-200 mg) or other pre-workout ingredients.
- Can be taken on workout days only if preferred.
For sleep support:
- Take 1-3 g taurine 30-60 minutes before bedtime.
- Often combined with magnesium glycinate 200-400 mg.
- Note: effects on sleep are individual; some find it helpful, some find no effect.
For cardiovascular support (no diagnosed disease):
- 2-3 g daily, divided or single dose.
- Monitor blood pressure at home periodically.
For insulin sensitivity/metabolic support:
- 2-3 g daily with meals.
- Combined with dietary and exercise interventions.
Intermediate Protocol (targeted therapeutic support with clinical indication):
For individuals with specific conditions where taurine has evidence-based application: congestive heart failure under cardiology care, type 2 diabetes with suboptimal glycemic control, NAFLD, documented hypertension, or longevity-focused stack integration.
Month 1 (escalation):
- Taurine 2 g twice daily (4 g total) for first month.
- Monitor: blood pressure, pulse, subjective energy, any GI symptoms.
- Consider baseline labs: HbA1c if diabetic, ALT/AST if NAFLD, BNP or NT-proBNP if CHF (under cardiology).
Month 2-3 (target dose):
- Taurine 3 g twice daily (6 g total) if well tolerated and the indication supports higher dose.
- For CHF: typically 3 g three times daily (9 g) under cardiology supervision.
- For diabetes: 1.5-3 g twice daily.
- For hypertension: 3 g twice daily.
- For NAFLD: 3 g twice daily.
- Recheck subjective markers and relevant labs.
Month 4-6 (consolidation):
- Adjust based on response. Partial responders may benefit from continued therapy. Non-responders at 3 months may discontinue.
- Long-term maintenance: once therapeutic benefit is achieved, often can reduce to maintenance dose of 2-3 g daily.
Specific conditions:
For congestive heart failure (under cardiology care):
- Typical protocol: taurine 2-3 g three times daily (6-9 g total).
- Duration: 3-6 months initial trial, then reassessment.
- Monitor: NYHA functional class, ejection fraction (if repeat echocardiogram), BNP/NT-proBNP, weight, edema.
- Do not stop or modify heart failure medications based on taurine response.
For type 2 diabetes (under endocrinology or primary care):
- 1.5-3 g twice daily × 3 months.
- Monitor HbA1c quarterly and compare to baseline.
- Continue standard antidiabetic medications; taurine is adjunctive.
For NAFLD (under gastroenterology or primary care):
- 2-3 g twice daily × 3-6 months.
- Monitor ALT, AST, and (if available) imaging.
- Combined with dietary changes, weight loss, and standard care.
For hypertension (under primary care or cardiology):
- 1.5-3 g twice daily.
- Monitor home blood pressure; do not stop prescribed antihypertensives based on taurine.
For longevity stack integration:
- 2-3 g daily as part of comprehensive approach including magnesium, vitamin D, omega-3, creatine, and others.
- Reassess stack periodically.
Advanced Protocol (high-dose clinical applications or investigational longevity use):
These protocols involve higher doses or combination therapies requiring medical supervision and higher confidence in the rationale.
MELAS mitochondrial disease (under neurology/genetics care):
- Taurine 9-12 g daily, divided TID or QID.
- Duration: lifelong as per MELAS treatment protocols.
- Monitor: frequency of stroke-like episodes, lactic acidosis, functional status, quality of life.
- This is FDA-approved in Japan as an orphan drug; outside Japan often used on clinical compassionate basis.
- Important: taurine is adjunctive; not a replacement for other MELAS management.
High-dose longevity stack (investigational, self-experimental):
- Based on Singh 2023 mouse dosing extrapolated to humans (approximately 3-6 g daily for a 70-kg adult).
- Typical protocol: taurine 3 g twice daily (6 g total).
- Duration: indefinite; biomarker-based reassessment every 6-12 months.
- Combined with: magnesium glycinate 400 mg, vitamin D 5000 IU, omega-3 3 g, creatine 5 g, NMN or NR per separate protocols.
- Monitor: blood pressure, metabolic panel, HbA1c, lipid panel annually; inflammatory markers (hsCRP, homocysteine) annually; consider aging biomarkers (epigenetic clock, GlycanAge) if interested in tracking.
GlyNAC + taurine stack (for older adults targeting aging biomarkers):
- Following Kumar 2022 (PMID 34918916) and related work.
- N-acetylcysteine 1200 mg daily
- Glycine 5 g daily (split doses)
- Taurine 2-3 g daily
- Duration: 6-12 month trial, then reassess.
Severe NAFLD/NASH (under hepatology care):
- Taurine 4-6 g daily combined with standard therapy.
- Monitor hepatic labs and imaging every 3-6 months.
Post-surgical or critical illness recovery:
- Taurine 2-4 g daily combined with standard nutritional support.
- Often used in ICU settings as part of comprehensive amino acid supplementation.
Critical considerations for advanced protocols:
Blood pressure monitoring: High-dose taurine combined with antihypertensive medications requires monitoring to avoid hypotension. Start at lower dose and titrate.
Drug interactions: Review full medication list before high-dose taurine. Particular attention to:
- Lithium (monitor levels)
- Antihypertensives (monitor blood pressure)
- Insulin/antidiabetics (monitor glucose)
- CNS depressants (monitor for additive sedation)
- Bile acid sequestrants (timing separation)
Laboratory monitoring for advanced use:
- Baseline: CBC, comprehensive metabolic panel, lipid panel, HbA1c (if diabetic), inflammatory markers
- 3-month: repeat above; assess response
- 6-month: continue monitoring; reassess dose
- Annual thereafter for chronic users
Discontinuation: No physiological withdrawal. Taurine benefits may persist for days to weeks after stopping due to tissue storage. Some users cycle taurine (3 months on, 1 month off) though no data support cycling vs continuous use.
Pregnancy considerations: Doses up to 3 g are generally considered safe; high-dose (>6 g) protocols should be held during pregnancy unless specifically prescribed for MELAS or other established indication.
Surgical considerations: No clear requirement to hold taurine before surgery. Discuss with surgical team; some surgeons prefer to discontinue most non-essential supplements 1-2 weeks preoperatively.
Dose adjustment for renal impairment:
- Mild-moderate (CrCl 30-60): no adjustment typically needed
- Severe (CrCl <30): consider dose reduction, monitor for any adverse effects
- Dialysis: insufficient data; discuss with nephrology
The fundamental principle for advanced taurine use: Taurine has a wide therapeutic window and excellent safety profile, but higher doses do not necessarily produce proportionally greater benefits. For most users, 2-3 g daily captures the majority of documented benefits. Higher doses are appropriate for specific indications (MELAS, CHF) or aggressive longevity stacking, but should be undertaken with monitoring and realistic expectations given the current state of human trial evidence.
Commonly Stacked With
Taurine stacks well with many common supplements due to its favorable safety profile and mechanistic versatility. Several specific combinations have particular rationale.
Magnesium pairing: Taurine and magnesium are both involved in calcium handling, cardiac function, and osmoregulation. Magnesium taurate (a salt combining the two) has been used specifically for cardiovascular applications and is a reasonable formulation for those prioritizing heart health. Alternative: take magnesium glycinate with separate taurine powder. Both should be foundational for most longevity-focused users. See /compound/magnesium for comprehensive magnesium guidance.
Creatine synergy: Both taurine and creatine accumulate in muscle and brain at high concentrations. Both are osmolytes. Both support cellular energy handling (creatine through phosphocreatine, taurine through mitochondrial function). Supplementation with both is complementary and does not show significant antagonism. Combined doses: creatine 3-5 g plus taurine 2-3 g daily is a reasonable performance and longevity stack. See /compound/creatine for full creatine guidance.
Glycine pairing: Glycine and taurine are both organic osmolytes, both modulate inhibitory neurotransmission (glycine through glycine receptors, taurine partially through glycine receptors), and both conjugate bile acids. Some trials of combined glycine and taurine (NAC plus glycine plus taurine) show additive benefits on glutathione, inflammation, and mitochondrial function. Doses: glycine 3-5 g plus taurine 1-3 g daily. Both safe. See /compound/glycine.
N-acetylcysteine (NAC) stack: NAC provides cysteine for glutathione synthesis; cysteine is also the precursor for taurine biosynthesis. Combined NAC plus glycine plus taurine approaches ("GlyNAC" plus taurine) have been studied for glutathione restoration and aging markers with promising preliminary results. Kumar 2022 (PMID 34918916) tested GlyNAC in older adults with promising healthspan effects. Doses: NAC 600-1200 mg, glycine 3-5 g, taurine 1-3 g daily.
Omega-3 fatty acids: No direct interaction but complementary cardiovascular effects. Both support vascular function, reduce inflammation, and favor cardiovascular outcomes. No dose adjustments needed. See /compound/omega-3-fatty-acids.
Vitamin D and vitamin K2: No direct interaction. Complementary foundational supplementation. See /compound/vitamin-d.
Berberine or metformin: Both metformin and berberine improve insulin sensitivity and mitochondrial function; taurine supports similar pathways through different mechanisms. Combined use reasonable, monitor for any additive hypoglycemia in diabetic patients. See /compound/metformin.
NMN/NR (NAD+ precursors): No direct interaction. Complementary longevity support—taurine provides aging-related benefits via mitochondrial and tissue osmolyte pathways; NAD+ precursors provide benefits via sirtuin activation and mitochondrial biogenesis. Combined use reasonable for comprehensive longevity stacks. See /compound/nmn and /compound/nr.
Rapamycin: No direct interaction. Both targeted at longevity through different mechanisms (rapamycin via mTORC1 inhibition; taurine via unknown multi-modal mechanism). Combined use in human longevity stacks is emerging. See /compound/rapamycin.
Caffeine: The classic energy drink combination. Caffeine is a stimulant; taurine is mildly sedating or neutral. The combination is thought to provide caffeine's acute stimulation while taurine provides cardiovascular support and reduces caffeine-induced arrhythmia risk. Doses: 100-200 mg caffeine with 1-2 g taurine is typical. Note that effects attributed to "taurine" in energy drinks are largely caffeine effects.
Branched-chain amino acids (BCAAs): Taurine plus BCAAs may have additive effects on exercise performance and recovery. Doses: BCAAs 5-10 g with taurine 1-3 g pre-workout.
Beta-alanine: Both are amino sulfonic acid-like molecules; they share the taurine transporter (TauT) and may compete for uptake. Chronic high-dose beta-alanine has been shown to reduce tissue taurine in animal models. Clinical significance in humans is less clear. If stacking both, consider modest dose adjustments or timing separation. Discussed in athletic performance literature.
Ginseng, rhodiola, and adaptogens: No direct taurine interactions. Complementary stress-adaptation support.
Coenzyme Q10 (CoQ10) and PQQ: Complementary mitochondrial support. No dose adjustments needed.
Alpha-lipoic acid (ALA): Complementary antioxidant and metabolic support. Both may improve insulin sensitivity. No known interactions.
Curcumin: Complementary anti-inflammatory effect. No direct interaction. See /compound/curcumin.
Quercetin and other flavonoids: No direct interaction.
Fisetin and senolytic stacks: No direct interaction. Both may contribute to healthspan through different mechanisms. See /compound/fisetin.
Zinc and copper: No direct interaction with taurine.
What to avoid or time carefully:
- Avoid high-dose taurine (>4 g) with benzodiazepines, barbiturates, or other CNS depressants (additive sedation).
- Avoid high-dose taurine with substantial alcohol (both are hepatically processed, both have CNS effects).
- Monitor if combining with multiple antihypertensives (additive blood pressure reduction).
- Separate by 2+ hours from bile acid sequestrants (cholestyramine, colesevelam).
Timing strategy:
Morning dosing: Pre-workout or with breakfast is practical for those using taurine for exercise performance and cardiovascular support. 1-2 g pre-exercise is typical for athletic applications.
Bedtime dosing: Some users find taurine improves sleep quality due to mild GABAergic effect. 1-3 g at bedtime may work for this application.
Split dosing: For higher total doses (3-6 g daily), split into 2-3 portions through the day to improve absorption and tolerance.
With food vs fasted: Absorption is slightly higher when fasted, but tolerance is better with food. For most users, with-food dosing is preferable.
Stack for longevity focus:
- Taurine 2-3 g (once or split dose)
- Magnesium 200-400 mg (glycinate)
- Vitamin D 2000-5000 IU
- Omega-3 1-3 g EPA/DHA
- Creatine 3-5 g
- CoQ10 or ubiquinol 100-200 mg (with age)
Stack for cardiovascular focus:
- Taurine 3 g (may split)
- Magnesium taurate or magnesium glycinate
- Omega-3 2-3 g EPA/DHA
- CoQ10 200 mg
- Hawthorn or garlic extract (for some)
Stack for athletic performance:
- Taurine 2 g pre-workout
- Creatine 5 g daily
- Beta-alanine 3-5 g (note taurine transporter competition)
- Citrulline 6-8 g pre-workout
- BCAAs or EAAs around training
Stack for cognitive and sleep focus:
- Taurine 1-2 g evening
- Magnesium glycinate 400 mg evening
- L-theanine 200 mg (for some users)
- Glycine 3 g pre-sleep
Long-term monitoring: For individuals on >3 g daily taurine long-term, no specific monitoring is required beyond annual comprehensive health labs. Plasma taurine measurement is not clinically validated as a therapeutic target beyond confirming gross adequacy. Monitor blood pressure at initiation and periodically if on antihypertensive medications.
Side Effects & Safety
Contraindications
Taurine has one of the cleanest contraindication profiles among widely used supplements. Absolute contraindications are rare, and most situations requiring caution are relative rather than absolute. **Absolute contraindications:** - Known hypersensitivity to taurine or excipients (extremely rare) - No other absolute contraindications documented **Strong relative contraindications (medical supervision recommended):** *Pregnancy with high-dose protocols:* Standard supplementation (≤3 g daily) is considered safe and even beneficial given taurine's role in fetal development. Doses above 3 g should only be used with obstetric input. MELAS and other specific indications requiring high-dose taurine during pregnancy should be managed by specialists. *Bipolar disorder:* Theoretical concern that GABAergic effect could potentially affect mood. Clinical evidence is absent, but caution reasonable pending data, particularly for doses above 3 g. *Severe renal impairment (CrCl <30):* Taurine is primarily renally excreted. Accumulation in advanced kidney disease is theoretical concern. Monitor if supplementing; consult nephrology for dialysis patients. *Severe hepatic disease:* Taurine is well-tolerated in most liver disease and may be beneficial in NAFLD/NASH and hepatic encephalopathy. No strong contraindication, but high doses in Child-Pugh C cirrhosis warrant specialist input. **Situations requiring careful dose consideration:** *Cardiovascular patients on multiple medications:* Blood pressure-lowering effect may be additive with antihypertensives. Start at lower dose, monitor BP. *Diabetic patients on tight glycemic control:* Modest insulin-sensitizing effect may require adjustment of insulin or sulfonylurea doses. Monitor glucose. *Elderly patients on multiple CNS-active medications:* Mild sedative effect may be additive with benzodiazepines, opioids, or sleep medications. Consider morning dosing. *Children:* Pediatric supplementation is generally limited to infant formula (standard practice), MELAS treatment (orphan drug), and specific medical indications. Routine pediatric supplementation is not evidence-based and should be guided by pediatricians. *Seizure disorders:* Taurine has weak anticonvulsant properties that could theoretically interact with prescribed anticonvulsants. Not a contraindication, but informing the neurologist is appropriate. **Drug interactions requiring attention:** *Lithium:* Taurine may affect renal handling of lithium. Monitor lithium levels if co-administered. *Antihypertensive medications (all classes):* Additive blood pressure reduction. Monitor particularly during initiation. ACE inhibitors, ARBs, beta-blockers, calcium channel blockers, diuretics—all may interact modestly. *Insulin and oral antidiabetic agents:* Potential for additive glucose reduction. Monitor glucose when starting taurine in diabetic patients on tight control. *Benzodiazepines, barbiturates, opioids, sleep medications:* Mild additive CNS depression possible, particularly at higher taurine doses. Not a hard contraindication but timing and dose consideration appropriate. *Alcohol:* No specific interaction, but both have hepatic processing and CNS effects. Avoid combining high-dose taurine with substantial alcohol. *Bile acid sequestrants (cholestyramine, colesevelam):* May reduce taurine absorption through bile acid complexation. Separate by 2 hours. *Anticonvulsants:* Taurine's mild GABAergic effect could theoretically affect seizure threshold. Not a contraindication but clinical review appropriate. *Anticoagulants and antiplatelet agents:* Very mild antiplatelet effect; clinical significance minimal. Not a contraindication. *Immunosuppressive medications:* No known interactions. Generally safe. *Chemotherapy agents:* Limited data; no known direct interactions, but patients undergoing cancer treatment should discuss all supplements with oncology team. **Situations where taurine supplementation is NOT recommended:** *"Mega-dosing" for athletic performance:* Diminishing returns above 3 g per dose for most acute applications. Chronic supplementation at 2-3 g daily is more effective than infrequent high doses. *Children without specific medical indication:* Infant formula supplementation is different from pediatric supplementation. Routine supplementation in healthy children is not evidence-based. *Acute severe illness:* If critically ill and unable to take oral supplements, taurine should not be continued outside hospital-directed care. *Replacement for evidence-based therapy:* Taurine is adjunctive for conditions like CHF, hypertension, and diabetes—not a replacement for standard medical therapy. **When to stop taurine supplementation:** Immediate discontinuation warranted for: - Symptomatic hypotension (dizziness, fainting), particularly if on antihypertensive medications - Persistent severe GI distress despite formulation change and food co-administration - Any new neurological symptoms without another clear explanation - Pregnancy if on doses >3 g (reduce to maintenance; discuss with obstetrics) - Scheduled elective surgery (reasonable but not strictly required to hold 1-2 weeks prior) Gradual reduction reasonable for: - Resolution of original indication (e.g., CHF stable on other therapy) - Desire to reduce supplement burden - Shift to dietary adequacy if now eating more animal protein **Monitoring recommendations by use case:** *Foundational daily (1-3 g):* No routine monitoring required beyond annual complete health assessment. *Therapeutic dose (4-6 g × 3+ months for specific indication):* Baseline and 3-month labs relevant to the indication (e.g., HbA1c, lipids, BP, LFTs). *High-dose (>6 g chronically):* Clinical monitoring appropriate to the indication; typically under specialist care. **Pre-surgical considerations:** Not typically required to hold taurine before surgery given clean pharmacology profile. Discuss with surgical team; some surgeons prefer discontinuation of most non-essential supplements 1-2 weeks preoperatively as general policy. **Dose adjustments:** *Renal impairment:* - CrCl >60: no adjustment - CrCl 30-60: monitor; consider modest dose reduction if symptoms - CrCl <30: consult nephrology; likely dose reduction warranted - Dialysis: insufficient data; specialist input required *Hepatic impairment:* - Compensated cirrhosis: no specific adjustment; may be beneficial - Decompensated cirrhosis: specialist input; likely lower doses appropriate *Elderly:* - Generally no dose adjustment needed, but elderly may be more sensitive to BP effects - Start at lower dose and titrate; review medication list for interactions **Counseling points for new users:** - Expect subtle effects over weeks; taurine is not a rapid-acting supplement for most indications - Tissue loading occurs over time; benefits may persist after discontinuation - Most benefit occurs at 2-3 g daily; higher doses are not necessarily better for general users - Combination with magnesium is synergistic for cardiovascular focus - Quality matters; choose third-party tested products
Additional Notes
Taurine dosing is expressed directly as elemental taurine (no conversion factor needed—1 g taurine = 1 g taurine, unlike zinc where elemental content varies by salt form).
Commonly used taurine doses by indication:
Foundational longevity and wellness support:
- 1-3 g daily (single dose or split)
- Most common consumer supplementation range
Cardiovascular support (non-clinical):
- 2-3 g daily
Exercise and athletic performance:
- 1-2 g pre-workout
- 2-3 g daily if chronic training support
Sleep support:
- 1-3 g at bedtime
Congestive heart failure (under cardiology supervision):
- 3 g three times daily (9 g total) per Azuma protocol
Type 2 diabetes adjunct:
- 1.5-3 g twice daily (3-6 g total)
Hypertension adjunct:
- 1.5-3 g twice daily
NAFLD:
- 2-3 g twice daily (4-6 g total)
MELAS mitochondrial disease:
- 9-12 g daily, divided TID or QID (pharmaceutical dose)
Vegan/vegetarian maintenance:
- 1-2 g daily to compensate for zero dietary intake
Pregnancy/lactation (if supplementing beyond prenatal):
- Typically ≤3 g daily unless specifically prescribed
Upper safety limits:
- European Food Safety Authority Acceptable Daily Intake: 6 g/day for adults
- Clinical trials have used up to 12 g/day in MELAS without systematic toxicity
- Dose-limiting factor at higher doses is typically GI tolerance rather than physiological toxicity
Timing and food considerations:
With food: Reduces GI upset risk but slightly reduces absorption. Most users prefer with-food dosing.
Empty stomach: Slightly better absorption (plasma peaks in 1-1.5 hours). Higher GI upset risk, particularly at doses above 3 g.
Split dosing: For total daily doses above 3 g, splitting into 2-3 portions improves both absorption and tolerance.
Morning vs evening:
- Morning: Useful for exercise support; aligns with typical caffeine intake
- Evening: Useful for sleep; some users find it sedating
- Flexible dosing: Most users can choose based on subjective response
Powder vs capsule forms:
Powder:
- Pros: Flexible dosing, generally less expensive per gram, fewer capsules to swallow
- Cons: Requires scale or scoop, slightly less convenient
- Best for: Those taking doses >3 g daily, budget-conscious users, those who prefer flexibility
- Mix with water or add to protein shake; taste is mildly bitter but tolerable
Capsules:
- Pros: Convenient, precise dosing, easier travel
- Cons: Need to swallow multiple capsules for higher doses (typical 500 mg per capsule = 4-6 capsules for 2-3 g)
- Best for: Moderate doses (<3 g daily), convenience-focused users
Effervescent tablets/liquid:
- Less common formats; tend to include flavoring agents and sweeteners
- Generally fine but check for added sugars
Storage:
- Room temperature, dry location
- Keep out of reach of children (though toxicity risk is lower than most supplements)
- Shelf life: typically 2-3 years in original packaging
- Powder stored with moisture-absorbing silica packet remains stable; clumping suggests humidity exposure but doesn't typically indicate degradation
Quality considerations:
Pharmaceutical-grade vs supplement-grade:
- Pharmaceutical-grade is higher purity, more expensive, used in clinical trials
- USP-grade supplement taurine is generally sufficient for consumer use
- Third-party testing (NSF, Informed Choice, USP) provides additional confidence
Source:
- Most commercial taurine is synthesized via chemical processes (often from ethylene oxide + sulfite). Vegan/vegetarian appropriate since no animal source required.
- Some labels indicate "plant-derived" or "synthetic" — both are fine
- Some older products used animal-derived taurine; this is no longer typical
Country of origin:
- China produces the majority of world supply; quality varies
- Reputable manufacturers source from facilities with appropriate quality control regardless of country
What to look for on supplement labels:
- Taurine content clearly stated (per capsule or per scoop)
- Quality certifications (NSF, USP, Informed Choice, Clean Label Project)
- Absence of unnecessary additives; if possible pure taurine only
- Third-party testing reports available on request
Distinguishing products:
- "Taurine 500 mg" = 500 mg elemental taurine (standard)
- "Taurine complex" or "taurate" = often includes mineral salts (magnesium taurate, zinc taurate); elemental taurine content varies
- "L-Taurine" = taurine (the L designation is often unnecessary since taurine is achiral, but labels use it for marketing)
Combination products:
- Magnesium taurate: typically 125 mg elemental magnesium per capsule, with proportional taurine. Useful for cardiovascular focus.
- Creatine + taurine pre-workout blends: useful for athletic applications
- Sleep stacks (taurine + glycine + magnesium): useful for sleep support
- Longevity stacks (taurine + NMN + creatine + others): reasonable for comprehensive approach
Overdose and missed doses:
- Missed single daily dose: resume normal schedule; no need to double up
- Missed multiple days: resume normal schedule; taurine tissue stores are stable
- Accidental high-dose ingestion (up to 20 g): expect GI distress, self-limited; contact poison control if severe
- No known acute toxic dose in adults; children should take age-appropriate amounts only
Monitoring during chronic high-dose use:
- Blood pressure if on antihypertensive medications
- Glucose if on antidiabetic medications
- No specific lab monitoring required for most users
- Annual comprehensive health assessment appropriate for anyone on chronic supplementation
Frequently Asked Questions
What is the recommended Taurine dosage?
Dosage for Taurine varies by protocol. Consult a qualified healthcare provider.
How often should I take Taurine?
Administration frequency depends on the specific protocol. Consult current research literature.
Does Taurine need to be cycled?
Cycling requirements depend on the protocol. Follow established research guidelines.
What are Taurine side effects?
Taurine has an exceptionally favorable safety profile across decades of extensive human use. Most individuals tolerate typical supplementation doses (1-6 g/day) without adverse effects. The European Food Safety Authority has established an Acceptable Daily Intake of 6 g/day for adults, and doses up to 10-12 g/day have been used in clinical trials for MELAS and advanced CHF without systematic toxicity. **Common mild side effects (typically at higher doses):** - **Gastrointestinal discomfort:** Mild nausea, bloating, or loose stools occur in a small percentage of users, particularly at doses above 3 g taken on an empty stomach. Usually resolves with reduced dose or administration with food. - **Headache:** Occasional reports, typically self-limited. - **Dizziness or lightheadedness:** May relate to taurine's mild blood pressure-lowering effect in susceptible individuals (particularly those already on antihypertensive medication or with low baseline blood pressure). - **Sedation:** Partial GABA-A agonism can cause mild drowsiness, particularly at higher doses or in individuals sensitive to GABAergic effects. Some users find taurine improves sleep when taken at bedtime; others find it sedating enough to avoid daytime use. - **Fatigue:** Paradoxically, some users report fatigue or lethargy with high doses; may relate to sedation or blood pressure effects. **Hypotension:** Taurine's antihypertensive effect is usually modest (~4-5 mmHg systolic reduction) but can be additive with other blood pressure-lowering medications or with low baseline blood pressure. Monitor in patients on ACE inhibitors, ARBs, beta-blockers, calcium channel blockers, or diuretics. **Bipolar disorder — theoretical concern:** Because taurine may have mild GABAergic effects, there is theoretical concern about precipitating mood changes in bipolar disorder. Clinical evidence is absent, but caution is reasonable pending data. **Drug interactions:** *Lithium:* Taurine may increase lithium retention (theoretical). Monitor lithium levels if co-administered. *Antihypertensive medications:* Additive blood pressure-lowering effect. Monitor for hypotension, especially during initiation. *Cholestyramine and other bile acid sequestrants:* May reduce taurine absorption through bile acid complexation; separate dosing by 2 hours. *Benzodiazepines, barbiturates, alcohol:* Potentially additive CNS depression. Avoid concurrent high-dose taurine with these agents. *Anticonvulsants:* Taurine may have mild anticonvulsant effects. Could potentially alter seizure threshold when combined with standard anticonvulsants. Consult prescriber. *Insulin and oral antidiabetic medications:* Potential for additive hypoglycemia in diabetic patients. Monitor glucose when starting taurine in patients on tight glycemic control. *Anticoagulants and antiplatelet agents:* Taurine has mild antiplatelet effects. Theoretical additive risk with warfarin, apixaban, clopidogrel, aspirin. Clinical significance usually minimal but worth mentioning. **Populations requiring caution:** *Pregnancy and lactation:* Taurine is considered safe and even beneficial during pregnancy based on its role in fetal development. Supplementation within 1-3 g/day is generally considered acceptable. High doses (>6 g) should only be used under medical supervision. *Pediatrics:* Infant formula is supplemented with taurine as standard practice. Pediatric supplementation beyond formula is uncommon and should be guided by pediatric specialists. *Renal impairment:* Taurine is primarily renally excreted. Severe kidney disease may require monitoring of serum levels, though clinically significant accumulation has not been well documented. Patients on dialysis may have altered taurine handling. *Hepatic impairment:* Taurine synthesis occurs in the liver. Severe liver disease may reduce endogenous taurine synthesis, making supplementation potentially more important. No clear contraindication. *Cardiovascular disease:* Taurine is generally beneficial in heart failure; no cardiac contraindications. Patients with arrhythmias on antiarrhythmic drugs should discuss with cardiology before starting. *Seizure disorders:* May have mild anticonvulsant effect. Discuss with neurology if concurrent with standard anti-seizure medications. **Rare but notable issues:** *Energy drink concerns:* The adverse effects often attributed to energy drinks (palpitations, anxiety, insomnia, arrhythmias) are primarily caffeine effects. Taurine at 1-2 g is unlikely to contribute materially. However, the combination has been questioned by some regulatory bodies; European Food Safety Authority has reviewed multiple times and consistently concluded no specific taurine-caffeine safety concern at typical serving sizes. *Sulfite sensitivity:* Theoretical concern due to taurine's sulfur group, but no clear clinical correlation. *Phenylketonuria (PKU):* Not affected by taurine use; taurine does not contain phenylalanine. *Salicylate sensitivity:* Unrelated; no cross-reactivity. **Pharmaceutical-grade vs supplement-grade considerations:** *Purity:* High-quality taurine supplements are generally well-purified. Pharmaceutical-grade taurine (used in MELAS treatment) meets higher purity standards. For general supplementation, USP-grade or equivalent is sufficient. *Additives and fillers:* Some capsule products contain fillers or excipients that may cause minor GI issues; powder forms avoid these. *Counterfeit or adulterated products:* Rare but documented. Purchase from reputable manufacturers with third-party testing. **When to reduce or discontinue:** - Persistent GI discomfort despite taking with food and reducing dose - Excessive sedation or fatigue - Symptomatic hypotension (particularly in patients on antihypertensive medications) - Any unusual symptoms that appeared after starting taurine and don't have another clear explanation - Pregnancy (except standard 1-3 g/day maintenance with obstetric input) - Scheduled elective surgery (hold 1-2 weeks preoperatively for caution, though not strictly required) **Signs suggesting dose should be reduced rather than discontinued:** - Mild GI upset: try dividing dose or taking with food - Drowsiness: try morning-only dosing or reduce dose - Headache: try reducing dose by 50% - Mild lightheadedness: ensure adequate hydration; reduce dose if persistent **Withdrawal considerations:** No physiological withdrawal syndrome has been documented with taurine discontinuation. Tissue taurine depletes gradually, so benefits accrued from long-term supplementation may persist for days to weeks after stopping. There is no need to taper dose.
Where can I buy Taurine?
Visit our vendor directory to find trusted sources for Taurine.
Free 2026 Peptide Cheat Sheet — 50 pages, PDF
Dosing, reconstitution, stacks, half-lives, and vendor trust tiers. The reference we wish we had on day one.
